German drugmaker BioNTech plans to develop its first malaria vaccine and begin clinical trials by next year.
The ambitious turnaround time is thanks to the MRNA technology used to develop the Pfizer and Moderna coronavirus vaccines in under a year.
The only approved malaria vaccine, Mosquirix, took scientists at GlaxoSmithKline more than 30 years to develop.
Malaria kills more than 400,000 people annually, most of them children in sub-Saharan Africa.
Apart from vaccines and pills, countries - including Malawi, Tanzania and Kenya - use drones to find mosquito breeding grounds and kill the larvae before they hatch.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
Samson’s Take: Arrogance of Power, Shameful Policing
3 hours -
Burnley score late to draw with Manchester United at Old Trafford
6 hours -
Bayer Leverkusen extend unbeaten run to 46 games after draw with Stuttgart
6 hours -
Chelsea come from two goals down to draw against Aston Villa
6 hours -
Andre Ayew scores in Le Havre’s 3-3 draw with PSG
6 hours -
GPL 2023/24: Kotoko draw with Medeama; Samartex go 7 points clear of Nations FC
6 hours -
Mahama cuts sod for construction of new multipurpose Jakpa palace in Damongo
7 hours -
NSS management assists Papao fire victims
7 hours -
EXPLAINER: Will dumsor end soon?
8 hours -
IMANI Africa takes on EC, accuses it of lying and publishing half truths
8 hours -
Manasseh Azure calls for investigation and prosecution of those responsible for GRA/SML contract
9 hours -
Kwesi Atuahene: Ghana’s health capital depends on HealthTech – Africa Center for Digital Transformation
9 hours -
13 signs your wife is planning on leaving you and you have no idea
9 hours -
IMANI Africa: Ghana’s EC’s dangerous and pathological conduct
9 hours -
If I speak there will be fire – Salah on Klopp row
10 hours